Clearmind Medicine (CMND) EBT (QoQ) (2022 - 2026)
Clearmind Medicine (CMND) EBT (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Clearmind Medicine | 537,495.91 | -13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 46.91% |
| Jan 31, 2026 | -409.28% |
| Oct 31, 2025 | 42.08% |
| Jul 31, 2025 | -71.02% |
| Apr 30, 2025 | 26.06% |
| Jan 31, 2025 | 11.44% |
| Oct 31, 2024 | 43.18% |
| Jul 31, 2024 | -135.39% |
| Apr 30, 2024 | 25.28% |
| Jan 31, 2024 | 71.38% |
| Oct 31, 2023 | -600.53% |
| Jul 31, 2023 | 61.92% |
| Apr 30, 2023 | 19.43% |
| Jan 31, 2023 | -19.51% |
| Oct 31, 2022 | -6.98% |
| Jul 31, 2022 | 19.24% |
| Apr 30, 2022 | -11.16% |